Mohs micrographic surgery in the surgical treatment paradigm of melanoma in situ and invasive melanoma: A clinical review of treatment efficacy and ongoing controversies
Journal of the American Academy of Dermatology · 2024-09 · 91 (3) · 499-507
DOI: 10.1016/j.jaad.2024.05.024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American Academy of Dermatology, 2024-09. Verfasst von Payal Shah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Dartmouth Health, Lebanon, New Hampshire. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Mohs Surgery. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 63 Literaturangaben.
Abstract (Originalsprache)
Mohs Micrographic Surgery (MMS) for treatment of melanoma offers several advantages over wide local excision (WLE), including complete histologic margin evaluation, same-day resection and closure, and sparing of healthy tissue in critical anatomic sites. Recently, a large volume of clinical data demonstrating efficacy in MMS treatment of melanoma was published, leading to emerging patient safety considerations of incurred treatment costs, risk of tumor upstaging, and failure of care coordination for sentinel lymph node biopsy (SLNB). MMS offers a safe, effective, and value-based treatment for both melanoma in situ (MIS) and invasive melanoma (IM), particularly with immunohistochemistry use on frozen sections. Compared to wide local excision, MMS treatment demonstrates similar or improved outcomes for local tumor recurrence, melanoma-specific survival, and overall survival at long-term follow-up. Tumor upstaging risk is low, and if present, alteration to clinical management is minimal. Discussion of SLNB for eligible head and neck IM cases should be done prior to MMS. Though challenging, successful multidisciplinary coordination of SLNB with MMS has been demonstrated. Herein, we provide a detailed clinical review of evidence for MMS treatment of cutaneous melanoma and offer recommendations to address current controversies surrounding the evolving paradigm of surgical management for both MIS and invasive melanoma (IM).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Dartmouth Health, Lebanon, New Hampshire.
- Department of Dermatology, Dartmouth Health, Lebanon, New Hampshire; Department of Medicine, Dartmouth Health, Lebanon, New Hampshire.
- Department of Dermatology, University of Florida College of Medicine, Gainesville, Florida; Department of Dermatology, University of Connecticut School of Medicine, Farmington, Connecticut.
- Department of Dermatology, Dartmouth Health, Lebanon, New Hampshire. Electronic address: Matthew.Leboeuf@hitchcock.org.
Zitieren
APA
Shah, P., Trepanowski, N., Grant-Kels, J. M., & LeBoeuf, M. (2024). Mohs micrographic surgery in the surgical treatment paradigm of melanoma in situ and invasive melanoma: A clinical review of treatment efficacy and ongoing controversies. Journal of the American Academy of Dermatology, 91(3), 499-507. https://doi.org/10.1016/j.jaad.2024.05.024
Vancouver
Shah P, Trepanowski N, Grant-Kels JM, LeBoeuf M. Mohs micrographic surgery in the surgical treatment paradigm of melanoma in situ and invasive melanoma: A clinical review of treatment efficacy and ongoing controversies. Journal of the American Academy of Dermatology. 2024;91(3):499-507. doi:10.1016/j.jaad.2024.05.024
BibTeX
@article{Shah2024,
author = {Shah, Payal and Trepanowski, Nicole and Grant-Kels, Jane M and LeBoeuf, Matthew},
title = {Mohs micrographic surgery in the surgical treatment paradigm of melanoma in situ and invasive melanoma: A clinical review of treatment efficacy and ongoing controversies},
journal = {Journal of the American Academy of Dermatology},
year = {2024},
volume = {91},
number = {3},
pages = {499--507},
doi = {10.1016/j.jaad.2024.05.024}
}
EUVIMED